The global medical device regulatory affairs market size is expected to reach USD 11.66 billion by 2030, registering to grow at a CAGR of 9.55% from 2024 to 2030 according to a new report by Grand View Research, Inc. Technological advancements in medical devices, such as AI and machine learning, increasing trends toward portable and smaller devices, and strict government regulations for medical devices are driving the market.
Medical equipment regulation is a vast and rapidly changing field that is often complicated by legal challenges. Even within one regulatory framework, legal terms and their definitions are not always consistent. As technology expands, software, machine learning, and algorithms become essential component of an increasing number of digital health resources. This presents new challenges as an increasing number of instruments fall under the regulatory framework.
Medical device companies have to deal with continuous changes in regulatory requirements, which can differ based on business activities and geographies. Noncompliance with the changing regulatory requirements can result in penalties and delays, which may lead to a loss of revenue. According to a survey sponsored by Genpact, 72.0% of executives from the life sciences industry consider regulatory compliance to be one of the top three challenges they face. Such factors are expected to support the demand for these services further.
Public organizations worldwide are providing funding to improve healthcare R&D. For instance, in March 2022, over USD 188.0 million was funded by the U.K. government to support NHS-led health research pertaining to diagnostics and treatments. Such investments in the future are expected to increase the number of new medical device launches, thus creating opportunities for medical device regulatory services. Such activities are expected to support the market in the forecasted period.
Request a free sample copy or view the report summary: Medical Device Regulatory Affairs Market Report
The regulatory writing and publishing segment dominated the market with the largest revenue share of 36.4% in 2023. This is due to a rise in the number of clinical trials, government support, and an increasing need to launch the product quickly
Based on type, the therapeutic segment accounted for the larger market share in 2023, due to increasing demand for equipment as a result of technological advancements in developed countries
There is a huge demand for outsourcing these services. Hence, the segment contributed to 58.2% of the global market in 2023. This is largely owing to the lack of in-house capabilities and ever-changing regulations for medical devices across the globe
Asia Pacific dominated the market and accounted for 37.82% of the revenue share in 2023. This is largely due to the expanding medical device market in India as a result of increased health awareness, a growing middle class, and government health initiatives.
Grand View Research has segmented the global medical device regulatory affairs market based on services, type, service provider, and region:
Medical Device Regulatory Affairs Service Outlook (Revenue, USD Million, 2018 - 2030)
Regulatory Consulting
Legal Representation
Regulatory Writing & Publishing
Product Registration & Clinical Trial Applications
Other Services
Medical Device Regulatory Affairs Type Outlook (Revenue, USD Million, 2018 - 2030)
Diagnostic
Therapeutic
Medical Device Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
In-house
Outsource
Medical Device Regulatory Affairs Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Medical Device Regulatory Affairs Market
ICON, Plc
Emergo
Freyr
Laboratory Corporation of America Holdings
IQVIA, Inc.
Intertek Group plc
SGS Société Générale de Surveillance SA
Promedica International
Integer Holdings Corporation
Medpace
"The quality of research they have done for us has been excellent..."